+996.7%
MRNA vs FRSH
+21.2%
+975.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FRSH | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -6.3% | +19.4% | +14.3% |
| 7D | +20.6% | -13.8% | +34.4% | +24.1% |
| 30D | +27.1% | +0.3% | +26.8% | +26.0% |
| 3M | +353.4% | +10.1% | +343.2% | +343.2% |
| 6M | +446.3% | +47.7% | +398.6% | +416.2% |
| YTD | +776.2% | +8.2% | +767.9% | +773.0% |
| All | +996.7% | +21.2% | +975.5% | +893.5% |
Cumulative growth
Daily Returns
Daily percentage return beside FRSH.
Daily Out/Under-Performance
Portfolio return minus FRSH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FRSH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FRSH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling